Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Well.. she has until the end of this week for the 45 days from her original post on X at 3:40pm 2024-01-23 or did I missing something.
"From the CEO: Exciting news! My chosen successor has accepted and I am thrilled for him to lead the company. My departure is set for the next 30-45 days. A formal transition announcement will come in the next few weeks. Cont..."
Yes it is dead, we are stuck at sea with a rotting boat and it's leaking at the same time. Hopefully we will have some update soon so we can be save !!
You got that right !! Anytime!! I even tried writing to them a few times with no reply.
I’m wondering if this went on and were we part of it? Man some update from this company would be so nice! Anything, just say Hi, yep still around. Still on track. Anything!!!!!
RESTANCE, Inc. (USOTC: ANCE) today announced plans to join in the 25th Anniversary AIDS Watch presented by the Elizabeth Taylor Foundation in Washington DC on Mach 26th and 27th, 2018.
Ouff Time to buy some more if you can!! I got some more at .71 you can get a better deal at .70 right now !! Everything is down right now not just this stock !! It will come back flying up !!
Good morning! Looking forward to get the skeleton remove!! Please!!
ANCE - skeleton on OTC will be remove soon !! The worst is was not even the companies fault. Advantage for us to get in cheap!! This will take off soon better buckle up!!
ANCE - 0.0042 / 0.0052 Dirt cheap !!
Man I wish I would have more money. .0052 is a steal better than my .01. Oh well the day will come for .10 +++
The reason for the skeleton head on otcmarkets. It will be remove soon !! Read the news of the 22 dec. 2017. Someone created a fraud site and they got ding on it without knowing.
"The link was to ancereport.com. The first I became aware of this promotion was when the representative at OTC Markets Group told me about it. The "ancereport' website and collateral promotion material was not sanctioned by RESTANCE. No one associated with RESTANCE had anything to do with the website or associated campaign."
"As stated in company releases, RESTANCE is concentrating its business development efforts at this time in East Africa and has indeed entered into a contract to produce condoms under the Playboy logo as part of a socially responsible campaign to contribute to the end of the AIDS Epidemic."
Then read the Disclosure on the otcmarkets site. Company is all good !!! More to our advantage. This will rise big time in a few weeks. Production is suppose to start early this year should have update soon !!!
ANCE !!! Don't forget to look up this one!!
ANCE -- check it out!!!!
ANCE -- check it out!!!!
OTCMarkets change there site and now you can't see the live bid and ask for free. Anyone knows another site you can see the live bid and ask for free?
Thanks
No, no, I'm starting to think all letters means something. It's a Legend of B... S... Will be holding for another week and see if he comes up with proof of something and that Legend of Kentucky see if that will ever come out.
I got in yesterday at .015 !! Nice finding Cheeky !!
Nice finding !! I just added some at .04!
Same here still holding strong for the Kentucky news.
What's up in Kentucky LGBS give us some News $$$
Good Morning LGBS. I think will see new highs in the next day or two!! Get them while they are hot and ready !!
I think we've been hitting higher highs in the last couple of weeks because awesome news is coming down the pipe. Just a matter of time for the right news and we gone !!! We want look back either!! Time to load!!
Yesterday PR was also post on this site. Hoping it means something.
https://www.oilandgas360.com/legends-business-group-inc-otc-lgbs-announces-new-lease-holdings-on-four-existing-wells/
The older PR doesn't tell me anything because Brian just join the team last June. I think I believe him that he actually was able to "first leases on four existing oil wells in Oklahoma" If you look in the PR bellow he brings with him knowledge and background in the Oil & Gas sector. Hoping we will rise !!!!
HENDERSON, NV / ACCESSWIRE / June 20, 2017 / Legends Business Group, Inc. (OTC PINK: LGBS) today announced that Bill Schaefer is leaving his position as Chief Executive Officer and member of the Board of Directors. Brian Estrada was appointed as Chief Executive Officer of the company. Estrada brings with him knowledge and background in the Oil & Gas sector for the company moving forward. As a commitment to the shareholders, the new CEO was able to get Bill Schaefer to retire all his shares of 650,000,000 common.
Everyone staring at the screen will it burst over .0074 !!! Lol !!
Any one wondering why it went up yesterday? Its because of this bellow!!!
IFXY Has Completed the Merger at the State Level.
Cryptocorp, [24.01.18 12:49]
We have just completed our merger with IFXY in the Nevada state level. This had to be done before FINRA. We tend to side with caution and be methodical in our approach with this transaction to build a solid foundation since all eyes are on crypto related companies, good and bad. So be patient, we will complete the process shortly.
Rumors are we might get a sponsor for phase 3 of the trial. I read that on Facebook. Not sure who but I guess it's good for us not using our investment money!!
Amazing!!! you keep going UP !! High of 1.61 CAD !!!!
Lol, people are trying to see how low they can buy before the power hour. You guys better bulk up for the power hour. PDXP $$$
Amazing we are flying !!
Awesome!!! We are moving !! Lets keep it up.
OMG, this is my vet that I had one time as my dog had major back issues. We had to go for a CT Scan these are amazing people and you can tell they are well knowledge. They are known around our east coast in Canada, after Quebec. From New-Brunswick, Nova-Scotia, P-E-I and Newfoundland. I know for sure they are making a great add on to the team for sure !!! So glad I have a big investment in this company !!! Almost have a tear in my eyes because they are really animal lovers as I am!! Good job Tetra !!! We were doing grocery and they came and talk to us how our dog was doing. Just amazing people!! Awesome work Tetra!!
TBPMF - will be the last month at these level. The only way it will go is up !!
Yes that was an awesome article. The best part last night I was watching my local news and this also air. The only thing its in french but if you forward to around 3:55 min. it says the same thing about the article from the link you had. The news might change for tomorrow if you don't watch it today.
http://ici.radio-canada.ca/tele/le-telejournal-acadie/2016-2017/
RCHA - Time to get in .0009 !!!!
No clue. I'm hoping to be above a dollar after summer. Then next year if they get FDA approval hopefully will see 5$ easy. If not still around 2$ they still have other product they are working on. If they could push that out to the market. To me it's like going to the bank and they lock down my money for 1 year. Instead of a 4%-8% increase it would be more like a 150% to 500% increase. I'm averaging at .69 cents. I'm not even touching these share until next summer for sure.
Hoping the end of Summer but if you look at the long picture will be a lot higher by next year !! This is my stock that I got money in and not even thinking of selling some before 2 years and hopefully will put me debt free for good !!
TBPMF (US) / TBP (CAD) this will run hard later on this year. It has so much potential. Just like Microsoft or Apple in the past but in medical Cannabis!!
JULY 13, 2017 – COMMENTS (1) | RELATED TICKERS: APHQF , SNY , GSK
The Original Announcement on the Aphria-Tetra Distribution Agreement:
On April 19, 2017, Tetra Bio-Pharma Inc. (CSE: TBP) (US OTCQB: TBPMF) and Aphria Inc. (TSX: APH) (US OTCQB: APHQF) announced a major partnership plan for the joint distribution of dried medical cannabis throughout the Canadian maritime provinces and the province of Quebec. Tetra and Aphria entered into the joint supply & distribution agreement with Aphria supplying dried medical cannabis under its ACMPR (Access to Cannabis for Medical Purposes) license and Tetra distributing that product after packaging the product using their proprietary process under their manufacturing CDSA (Controlled Drugs and Substances Act) dealer’s licence at its New Brunswick facility. Tetra and Aphria also announced in this news that they may expand into other provinces based on the successful outcome of the venture in these initial provinces.
The Three Month Update on the Partnership's Progress:
Three months later, on July 11, 2017, Tetra Bio-Pharma announced that "The initial demand forecasted in New Brunswick (one of the maritime provinces -- MM) for PPP001 using the ACMPR license is more than what we expected for sales. We are now putting in place the necessary manufacturing capabilities to address this increasing demand and to ensure the highest standards of quality control. We will look at launching PPP001 using the ACMPR license by the end of summer."
Conclusion & Analysis Based on the Update:
The only conclusion to draw from this is they are showing stronger than expected demand from pre-orders by retail outlets in New Brunswick and that probably translates pretty evenly over the rest of the provinces in this rollout. That is, it is not demand created by a certain location versus a different location, but is demand that is differentiated on the quality and price of the product. This is very high quality product and retail outlets know what customers are desiring, what they are ordering, and the conclusion of the retail outlets is to make strong pre-orders for Tetra's PPP001 medical cannabis. Furthermore, since it's not a demand created by a location but instead by quality and price, we can expect Tetra to do well in all the maritime provinces and the province of Quebec, and that success means they will be launching the product in the whole of Canada as per the news release on the Aphria agreement. The maritime provinces are New Brunswick, Nova Scotia, and Prince Edward Island and are located on the Canadian east coastline in the Atlantic region; their population is estimated at 2,000,000 in 2017. Quebec is the second largest Canadian province and has a population of 8.4 million with half of those living in Montreal. Thus the immediate total for that area is over 10 million people and Tetra has their manufacturing facility right in the heart of this region, which will lower shipping costs on an already lowest-cost produced product (see Aphria's latest quarterly and annual Sedar filing and related news release for more on that).
International Reach of Tetra Bio-Pharma Manufacturing & Distribution Center:
On the importance of the location the maritime provinces are well-known export centres via the Atlantic ocean. Quebec has access to multiple avenues of distribution via shipping, such as the St. Lawrence River, the Gulf of Saint Lawrence, the Arctic Ocean, James Bay, Hudson Bay and Ungava Bay. In Montreal, where half the population of Quebec resides, are located some of the largest inland Atlantic ports in the world, in fact. Through the St. Lawrence Seaway they have access to the Great Lakes as well as having a land border with some important US states. They border with Maine (which legalized recreational marijuana in the November 9th, 2016 elections), New Hampshire (MMJ state just passed HB 160 adding PTSD to the list of accepted ailments for medical cannabis; Gov. Sununu stated he will also sign the decriminalization bill HB 640), Vermont (H. 511 to legalize marijuana was amended and passed by the Vermont Senate; next step is House passage when they reconvene later this year or in January 2018; and the bill is expected to pass the House since a similar bill was passed earlier in 2017 by the House) and New York (the NY Senate passed S 5629 adding PTSD as a qualified ailment for the state's MMJ program). (See MPP Blog for more on states' medical and recreational MJ progress)
International Expansion Through Commercialization Partnerships:
The company announced in a corporate update earlier this week that they are "focused on expanding commercialization partnerships internationally for their product pipeline" and that they are receiving partnership inquiries not only in the USA, but also from Germany, Ireland, Brazil and Mexico. Canada has strong shipping channels both to Europe and Central and South America via the Atlantic. With the initial demand for their PPP001 product higher than their expectations, TBP has now been putting in place the necessary manufacturing capabilities to meet the demand load and ensure the product's high standard of quality and high quality-control processing. They are on schedule with their timetable for launch by the end of summer. It is likely they would like to have the launch begun before Q4 starts so they will have everything moving as they enter the last quarter of the year; while we may see a few weeks of sales go through in September, thereafter the sales of Q4 should be much stronger with thirteen weeks of sales. We can also expect that as each day passes, sales will continue increasing by a strong growth rate throughout 2018 as well. A recent 188 page industry analyst report by Azoth Analytics released in May 2017 covered all facets of the pharmaceutical industry market and growth (CAGR) expected for the coming years, highlighting in the study the first company in the world to bring dried medical cannabis into Phase III clinical trials, Tetra Bio Pharma ($65M USD market cap), along with the big names in big pharma, being nine major multi-billion dollar pharmaceutical companies. For a small research company to be included with such a major list of companies in their industry, there is a requirement to have found something substantial out about them, even disruptive for the marketplace. The first thought that comes to mind on what that would be is TBP's PPP001 dried cannabis as a prescription drug. Here is the list of companies covered in the Azoth report:
Pfizer ($199.45B) (NYSE:PFE)
Novartis ($185.475B) (NYSE:NVS)
Sanofi ($112.045B) (NYSE:SNY)
GSK ($101.269B) (NYSE:GSK)
AstraZeneca ($82.86B) (NYSE:AZN)
Allergan ($81.0B) (NYSE:AGN)
Endo Pharmaceuticals ($2.5B) (NasdaqGS:ENDP)
Purdue Pharma (Private, Top 20)
Boehringer-Ingelheim (Private, Top 20)
Tetra Bio-Pharma ($65M USD) (CSE:TBP)
The Tetra Bio-Pharma Mindset:
The mindset and practice of Tetra is that rather than reinventing the wheel, they find partners already well-versed in whatever it is where they have a need, and they partner up so they can work off of each other's strengths, creating a synergy and enabling significant cost savings. According to the company, they have opened lines of communications now with three of the majors and some thirty other pharma companies, and they announced news to this effect after being invited to the world's largest pharmaceutical conference and expo, just held in mid-June in San Diego this year. The company took the opportunity to update their shareholders through their Facebook page with this quote:
We just completed Bio International Conference in San Diego yesterday. OVER 30 meetings were completed including THREE major pharma companies. We are working hard to expand, build and accelerate our innovative pharmaceutical pipeline. Now we work to CLOSE future partnerships and move the company in a forward position of becoming a global leader in pharmaceutical cannabis."
Investing in the Pharmaceutical Industry:
Is investing in the pharmaceutical industry a wise decision? Certainly it is the consensus of financial writers who have studied how to survive major market corrections and crashes, even major economic crashes on scale with the Great Depression and the 2007 crash that one investment that has great sustainability is pharma. Everybody needs medicine at one time or another to maintain their health in order to deal with whatever else it is they need or have to do; without good health, what good is anything else. If you have a job offer but are not healthy enough to work, what good is a job offer to you. Good health is a priority to everyone. It is backed by government and it is backed by insurance companies. It is backed by the medical associations. It is backed by every major university in the world. It is backed by every hospital in the world.
The Value of Good Personal Due Diligence:
Recently, one writer was writing on his concerns about the bull market in general saying valuations overall were high and a recession was due. That is a general comment, yet the writer tried to target cannabis stocks with that reasoning. However, the evidence is in that even in economic crises people spend their available resources on pharmaceuticals, health food, groceries, razor blades, tooth brushes, as well as items such as cigarrettes, wine and beer, and a host of other similar things. People want to feel good and in their own way each of these help them do that. These are things people consider to be necessities that they can't or just don't want to live without. With an investment in Tetra Bio-Pharma, you are taking part in a company with tremendous annual growth potential in one of the fastest growing industry markets in the world; and in particular one with a pharmaceutical grade product that's able to be sold right now, today, to those looking for the highest quality for their current medical cannabis program they are with, but that also is moving into Phase III clinical trials so that the product can be prescribed as a medicine with an actual drug identification number (DIN) and be covered by medical insurance rather than how it is now, paid out of pocket by patients. It's no wonder to me why Azoth Analytics included Tetra Bio-Pharma in their report because the opiod crisis has everyone on edge from patients to doctors to governments and PPP001 is a disruptive factor coming into that marketplace for reason of which some of the major competitors in pharma will begin to partner with TBP.
Doing Due Diligence on Articles and Authors You May Research:
If fear of another collapse wasn't enough to selectively target cannabis stocks, the writer continued that cannabis investors should be afraid of a federal crackdown even although President Trump has long stated that he has many friends and supporters who use medical marijuana. Lest everyone forget, he is the one who selected Mr. Sessions for his role as attorney general and not the other way around. Furthermore, the US Congress and state congresses have increasingly passed favorable legislation, favorable bills in both houses of Congress, and the voters nationwide have continued to increasingly favor legalizing cannabis both for medical conditions and for recreational use. Add to that people are learning the difference in taking a dangerous opiod drug versus using medical marijuana to resolve their pain issues. While people have died from opiod overdose, barbituate overdose, heroin overdose, meth-amphetamine overdose, and even alcohol overdose (think university students who died in hazing incidents), I have never been to or heard of a funeral for someone who died from marijuana overdose. The writer simply rehashes old news that has already been priced into the market and every day is more a non-issue!
Be Ready to Sift Through a Lot of Bad Analysis; Refuse to be Spoonfed:
If that wasn't enough fearmongering via a market collapse and a federal crackdown, the same writer continued that financial institutions could turn cannabis companies' cash away because of fears of violating federal laws. But that is NOT something on the verge of happening but is already a major part of what cannabis companies go through in general. It is also priced into the market and on major changes offers strong upside potential for companies. MMJ companies have had to look harder than others for institutions to bank with, and some companies have started up to deal with that situation by transporting cash to a friendly bank or guarded vault location. Certainly not all financial institutions have a ban on cannabis cash and the situation is getting better through actions undertaken by the US Congress dealing with that specific issue in the last session of Congress. So the situation is getting better by the day. Irrational fears like these provide a great opportunity for investors to get in at a better price before the rest of the market enters. These are not really sound fears that are waiting to dampen prices, but irrational fears that have already had an effect on prices. So a smart investor studies what will happen once each of these issues is totally resolved (Congress defunding the DOJ in respect to cannabis in legal states like they did; Congress opening up banking to operate without fear in legal cannabis states, for example, which if the writer had read up on it, he would have found that Congress indeed has taken action on these issues!).
In Conclusion:
Remember to keep your thinking cap on when you read what people are disseminating these days, whether it's their opinions on cannabis, medical cannabis, the economy or anything else. Your best advice on any industry will come from within the industry itself, not from someone outside the industry and not from someone who doesn't invest in the industry. People tend to research best what they put their money into. I began investing in cannabis companies by watching the market back several years ago. Then after I had researched for a couple of years, I began by taking a small position in about a dozen companies. Those I began to follow closely and research and do the due diligence. Once I came to more fully grasp who the companies were, who the people running the companies were, what their products and services were, what their research was, who their partners were, I began to increase certain of those investments and divest of others. Then I turned from overall cannabis markets to place more attention on the pharmaceutical side of the industry, where most of the stocks I hold are now located. I consider Aphria to not only be a licensed producer but, due to their work with Tetra and their passion to produce a pharmaceutical grade product, also somewhat of a pharma company. That they along with their major partner Tetra are able to produce at the lowest cost among the industry really makes them a standout investment. Being the low-cost producer makes you disruptive to the rest of the market. For investors, when disruptive is on your side, that's a good thing. By that, YOUR company controls commodization of the key product being sold. (And yes, that same writer added commoditization as another fear to run investors off, but as you can see, one must look at it all with the right perception and analysis to see the real truth of the matter. As I came to the conclusion that I needed to greatly expand my investment in Tetra, Aprhia came along with a large investment in Tetra at that exact time. Holding both companies already as my two top favorites after three years of research, I had a headstart on all the research I felt I needed to take a stake. Last year people probably thought it would take Tetra years to make a profit, but today they are preparing to launch both 1) Phase III end-stage clinical trials based upon their highly successful Phase I clinical study of PPP001 and 2) distribute PPP001 backed by Aphria throughout Canada. Plus the company is stating they will be launching their natural health product lines this year as well. For me, I was never happier to have researched a company so well and have the opportunity to participate in what is now unfolding before our eyes.
Good luck, best regards,
Mighty Maven
So DRWN does it stand from Drowning. LOL!!someone needs to throw us a lifejacket. Get the audit out !!!
HAON is getting attention. Almost double the avg volume.
I've receive this presentation by e-mail. I'm subscribe to there news of the website.
http://s22.q4cdn.com/161737113/files/doc_presentations/2017/Tetra-IR-presentation-Updated-July-12-2017.pdf